34 related articles for article (PubMed ID: 9595033)
1. Synthesis of nitrogen mustard-based fluorophores for cell imaging and cytotoxicity studies.
Liang Y; Liang M; Li C; Wang D; Gong X; Zheng K
J Adv Pharm Technol Res; 2023; 14(1):6-11. PubMed ID: 36950465
[TBL] [Abstract][Full Text] [Related]
2. Brostallicin (PNU-166196)--a new DNA minor groove binder that retains sensitivity in DNA mismatch repair-deficient tumour cells.
Fedier A; Fowst C; Tursi J; Geroni C; Haller U; Marchini S; Fink D
Br J Cancer; 2003 Oct; 89(8):1559-65. PubMed ID: 14562032
[TBL] [Abstract][Full Text] [Related]
3. Mismatch repair deficiency is associated with resistance to DNA minor groove alkylating agents.
Colella G; Marchini S; D'Incalci M; Brown R; Broggini M
Br J Cancer; 1999 May; 80(3-4):338-43. PubMed ID: 10408835
[TBL] [Abstract][Full Text] [Related]
4. PNU 157977: a new potent antitumour agent exhibiting low in vivo toxicity in mice injected with L1210 leukaemia cells.
Baraldi PG; Balboni G; Romagnoli R; Spalluto G; Cozzi P; Geroni C; Mongelli N; Rutigliano C; Bianchi N; Gambari R
Anticancer Drug Des; 1999 Feb; 14(1):71-6. PubMed ID: 10363029
[TBL] [Abstract][Full Text] [Related]
5. Cinnamoyl nitrogen mustard derivatives of pyrazole analogues of tallimustine modified at the amidino moiety: design, synthesis, molecular modeling and antitumor activity studies.
Baraldi PG; Beria I; Cozzi P; Geroni C; Espinosa A; Gallo MA; Entrena A; Bingham JP; Hartley JA; Romagnoli R
Bioorg Med Chem; 2004 Jul; 12(14):3911-21. PubMed ID: 15210158
[TBL] [Abstract][Full Text] [Related]
6. Combinatorial identification of a novel consensus sequence for the covalent DNA-binding polyamide tallimustine.
Sunavala-Dossabhoy G; Van Dyke MW
Biochemistry; 2005 Feb; 44(7):2510-22. PubMed ID: 15709763
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, DNA binding, cytotoxicity and sequence specificity of a series of imidazole-containing analogs of the benzoic acid mustard distamycin derivative tallimustine containing an alkylating group at the C-terminus.
Brooks N; Lee M; Wright SR; Woo S; Centioni S; Hartley JA
Anticancer Drug Des; 1997 Oct; 12(7):591-606. PubMed ID: 9365504
[TBL] [Abstract][Full Text] [Related]
8. Selective DNA interaction of the novel distamycin derivative FCE 24517.
Broggini M; Erba E; Ponti M; Ballinari D; Geroni C; Spreafico F; D'Incalci M
Cancer Res; 1991 Jan; 51(1):199-204. PubMed ID: 1859575
[TBL] [Abstract][Full Text] [Related]
9. Sequence-specific DNA alkylation of novel tallimustine derivatives.
Marchini S; Cozzi P; Beria I; Geroni C; Capolongo L; D'Incalci M; Broggini M
Anticancer Drug Des; 1998 Apr; 13(3):193-205. PubMed ID: 9595033
[TBL] [Abstract][Full Text] [Related]
10. The discovery of a new potential anticancer drug: a case history.
Cozzi P
Farmaco; 2003 Mar; 58(3):213-20. PubMed ID: 12620417
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxics derived from distamycin A and congeners.
Cozzi P; Mongelli N
Curr Pharm Des; 1998 Jun; 4(3):181-201. PubMed ID: 10197039
[TBL] [Abstract][Full Text] [Related]
12. Hybrid molecules between distamycin A and active moieties of antitumor agents.
Baraldi PG; Preti D; Fruttarolo F; Tabrizi MA; Romagnoli R
Bioorg Med Chem; 2007 Jan; 15(1):17-35. PubMed ID: 17081759
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
